Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by alleyesonmeon Mar 22, 2022 6:11pm
90 Views
Post# 34536003

RE:Shelter Deal

RE:Shelter Deal Shelter has a cultivation license...Labs acquired shelter so yes....yes they do....Shelter was specifically for medical patients....perfect fit and under one roof!!! Love this deal...now they will be able to include medicinal flower on international shipments....a contributor on another forum posted this information released today atleast a month ago...he also stated they made two large shipments of pre-rolls acquired in the deal to Western Canada....much information in the pockets of management...the recovery begins...the market will catch on positively to this and were due for a re-rating in a higher price range. Management is clearly in prove it mode and I'm very bullish on this turnaround...tolling contract...international ramp up...API contract...many potentials brewing and primed...I believe they are in talks with pharma which is why they now have filed with the FDA...we will see...10x...20x...I feel this is very possible...
<< Previous
Bullboard Posts
Next >>